Nogo has been identified as a component of the central nervous system (CNS)
myelin that prevents axonal regeneration in the adult vertebrate CNS. Anal
ysis of Nogo-A has shown that an axon-inhibiting domain of 66 amino acids i
s expressed at the extracellular surface and at the endoplasmic reticulum l
umen of transfected cells and oligodendrocytes(1). The acidic amino terminu
s of Nogo-A is detected at the cytosolic face of cellular membranes(1) and
may contribute to inhibition of axon regeneration at sites of oligodendrocy
te injury(2,3). Here we show that the extracellular domain of Nogo (Nogo-66
) inhibits axonal extension, but does not alter non-neuronal cell morpholog
y. In contrast, a multivalent form of the N terminus of Nogo-A affects the
morphology of both neurons and other cell types. Here we identify a brain-s
pecific, leucine-rich-repeat protein with high affinity for soluble Nogo-66
. Cleavage of the Nogo-66 receptor and other glycophosphatidylinositol-link
ed proteins from axonal surfaces renders neurons insensitive to Nogo-66. No
go-66 receptor expression is sufficient to impart Nogo-66 axonal inhibition
to unresponsive neurons. Disruption of the interaction between Nogo-66 and
its receptor provides the potential for enhanced recovery after human CNS
injury.